Improving Drug Development: Molecular Devices and Cellesce Aim to Advance the Use of Organoids
Following our acquisition of Cellesce Ltd, Tanya Samazan from Instrument Business Outlook dove deep into conversation with Molecular Devices President Susan Murphy and Cellesce CEO Vicky Marsh-Durban about how their complementary expertise and technologies will accelerate organoid research.